Literature DB >> 33340417

SARS-CoV-2 candidate vaccines - composition, mechanisms of action and stages of clinical development.

Juan Rodriguez-Coira1,2,3, Milena Sokolowska1,4.   

Abstract

Entities:  

Keywords:  COVID; SARS-CoV; infections; vaccines

Year:  2021        PMID： 33340417     DOI： 10.1111/all.14714

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  10 in total

1.  An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant.

Authors:  Tushar Ahmed Shishir; Taslimun Jannat; Iftekhar Bin Naser
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.752

2.  Flattening the Curve of COVID-19 Vaccine Rejection-An International Overview.

Authors:  Wojciech Feleszko; Piotr Lewulis; Adam Czarnecki; Paweł Waszkiewicz
Journal:  Vaccines (Basel)       Date:  2021-01-13

3.  Allergic reactions to COVID-19 vaccinations-unveiling the secret(s).

Authors:  Oliver Pfaar; Vera Mahler
Journal:  Allergy       Date:  2021-06       Impact factor: 14.710

4.  Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital.

Authors:  Giovanni Paoletti; Francesca Racca; Alessandra Piona; Giulio Melone; Morena Merigo; Francesca Puggioni; Sebastian Ferri; Elena Azzolini; Michele Lagioia; Donatella Lamacchia; Giuseppe Cataldo; Maurizio Cecconi; Giorgio Walter Canonica; Enrico Heffler
Journal:  World Allergy Organ J       Date:  2021-04-08       Impact factor: 4.084

5.  EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.

Authors:  Milena Sokolowska; Thomas Eiwegger; Markus Ollert; Maria J Torres; Domingo Barber; Stefano Del Giacco; Marek Jutel; Kari C Nadeau; Oscar Palomares; Ronald L Rabin; Carmen Riggioni; Stefan Vieths; Ioana Agache; Mohamed H Shamji
Journal:  Allergy       Date:  2021-06       Impact factor: 14.710

6.  A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca.

Authors:  Marian S Boshra; Raghda R S Hussein; Marwa Mohsen; Ahmed A Elberry; Ahmed E Altyar; Mahmoud Tammam; Rania M Sarhan
Journal:  Vaccines (Basel)       Date:  2022-02-15

Review 7.  Vaccination and immunotherapies in neuroimmunological diseases.

Authors:  Alexander Winkelmann; Micha Loebermann; Michael Barnett; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2022-04-06       Impact factor: 44.711

8.  Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants.

Authors:  Pia Gattinger; Bernhard Kratzer; Inna Tulaeva; Katarzyna Niespodziana; Anna Ohradanova-Repic; Laura Gebetsberger; Kristina Borochova; Erika Garner-Spitzer; Doris Trapin; Gerhard Hofer; Walter Keller; Isabella Baumgartner; Ivan Tancevski; Musa Khaitov; Alexander Karaulov; Hannes Stockinger; Ursula Wiedermann; Winfried F Pickl; Rudolf Valenta
Journal:  Allergy       Date:  2022-04-15       Impact factor: 14.710

9.  Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines.

Authors:  Osama Abu-Hammad; Hamza Alduraidi; Shaden Abu-Hammad; Ahmed Alnazzawi; Hamzah Babkair; Abdalla Abu-Hammad; Ibrahim Nourwali; Farah Qasem; Najla Dar-Odeh
Journal:  Vaccines (Basel)       Date:  2021-06-01

10.  Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma.

Authors:  Bernhard Kratzer; Doris Trapin; Pia Gattinger; Teresa Oberhofer; Al Nasar Ahmed Sehgal; Petra Waidhofer-Söllner; Arno Rottal; Ulrike Körmöczi; Katharina Grabmeier-Pfistershammer; Gerhard H Kopetzky; Franz Tischer; Rudolf Valenta; Winfried F Pickl
Journal:  Vaccines (Basel)       Date:  2022-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.